Literature DB >> 12774926

Size and composition of T-cell receptor delta (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemia.

Taku Seriu1, Yvonne Stark, Dorothee Erz, Claus R Bartram.   

Abstract

We characterized 168 junctional regions of T-cell receptor delta (TCRD) rearrangements from 116 children with acute lymphoblastic leukemia (ALL) (101 with precursor B-cell ALL, 15 with T-cell ALL). Application of 101 allele-specific oligonucleotide (ASO) probes representing 85 Vdelta2Ddelta3, 10 Ddelta2Ddelta3, 3 Vdelta1Jdelta1, 1 Vdelta3Jdelta1, and 2 Ddelta2Jdelta1 junctions for the detection of minimal residual disease (MRD) revealed detection levels of 10(-4) to 10(-6) leukemia cells in the vast majority of cases (93 of 101). Of interest was that neither the N, D, P (nontemplated, diversity, palindromic) content and length of the junctional regions nor the number of nucleotides deleted from the flanking V, D, or J (variable, diversity, joining) elements correlated with the sensitivity of ASO probes. These data indicated that in ALL TCRD rearrangements can serve as suitable tools for the detection of MRD irrespective of the specific composition of the junctional region.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774926     DOI: 10.1007/bf02982646

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.

Authors:  C Guidal; E Vilmer; B Grandchamp; H Cavé
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

2.  Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.

Authors:  T M Breit; I L Wolvers-Tettero; K Hählen; E R van Wering; J J van Dongen
Journal:  Leukemia       Date:  1991-12       Impact factor: 11.528

3.  Alternative splicing restricts translation of rearrangements at the T-cell receptor delta/alpha locus.

Authors:  T E Hansen-Hagge; C Mahotka; R E Panzer-Grümayer; H J Reuter; K Schwarz; J J van Dongen; C R Bartram
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

4.  Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.

Authors:  M J Pongers-Willemse; O J Verhagen; G J Tibbe; A J Wijkhuijs; V de Haas; E Roovers; C E van der Schoot; J J van Dongen
Journal:  Leukemia       Date:  1998-12       Impact factor: 11.528

5.  T cell receptor Ddelta2Ddelta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

Authors:  T Seriu; D Erz; Y Stark; C R Bartram
Journal:  Leukemia       Date:  1997-05       Impact factor: 11.528

6.  Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.

Authors:  M J Pongers-Willemse; T Seriu; F Stolz; E d'Aniello; P Gameiro; P Pisa; M Gonzalez; C R Bartram; E R Panzer-Grümayer; A Biondi; J F San Miguel; J J van Dongen
Journal:  Leukemia       Date:  1999-01       Impact factor: 11.528

7.  Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.

Authors:  M Nakao; J W Janssen; T Flohr; C R Bartram
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

8.  Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.

Authors:  T Szczepański; A Beishuizen; M J Pongers-Willemse; K Hählen; E R Van Wering; A J Wijkhuijs; G J Tibbe; M A De Bruijn; J J Van Dongen
Journal:  Leukemia       Date:  1999-02       Impact factor: 11.528

9.  Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.

Authors:  T Seriu; T E Hansen-Hagge; D H Erz; C R Bartram
Journal:  Leukemia       Date:  1995-02       Impact factor: 11.528

10.  Cutting and closing without recombination in V(D)J joining.

Authors:  S M Lewis; J E Hesse
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.